Parkinson's disease is a neurodegenerative condition characterized by symptoms such as tremor, impaired balance, and slowness of movement. New research from Spain, ho...

Zurich, Switzerland, September 26, 2018 / B3C newswire / -- Liver4Life is a project of Wyss Zurich, a joint research and development center of the ETH Zurich and the ...

Keele, Darlington and London, 25 September 2018: Cobra Biologics (Cobra), an international contract development and manufacturing organisation (CDMO) of biologics and...

Amsterdam, 27th September 2018: Ahead of the inaugural edition of bioLIVE – the bioprocessing and manufacturing event opening October (9-11) in Madrid – CPhI Worldwid...

Swiss gene editing company CRISPR Therapeutics and US-based regenerative medicine firm ViaCyte have formed a strategic alliance to discover, develop and commerciali...

Dive Brief: Regeneron is broadening its research bets in immuno-oncology, partnership with Bluebird bio that will pair the New York biotech's antibody prowess wit...

Researchers from the University of Oxford's Department of Zoology have demonstrated pre-clinical success for a universal flu vaccine in a new paper published in Natur...

Schlieren / Zurich, Switzerland, September 18, 2018 / B3C newswire / -- Neurimmune today announced the achievement of a key preclinical milestone in the ongoing colla...

Results Healthcare, the leading corporate advisory firm focused on public and private healthcare and life sciences companies, today publishes its report looking at th...

Cambridge, UK, 24 September, 2018: Horizon Discovery Group plc (LSE: HZD) (“Horizon” or “the Company”), a global leader in gene editing and gene modulation technologi...